Craig Coopersmith, MD, FACS, FCCM
-
RoleCritical Care Medicine
-
Research Program
-
Practicing Since2000
Dr. Coopersmith is an eminent academic surgeon in the area of surgical critical care. As interim director of the Emory Critical Care Center (he served as associate director of the ECCC from 2009-2018), he is integral to a service that aims to deliver the highest quality, value, and access to critical care for patients in the southeastern USA and leads the nation in designing, testing, and implementing innovations in critical care. Partnering throughout Emory's Woodruff Health Sciences Center, the center offers access to state-of-the-art care and experimental treatments. The Emory Critical Care Center also has a comprehensive training mission that includes educating fourth-year Emory medical students; interns and residents from internal medicine, general surgery, anesthesiology, emergency medicine, neurology, and neurosurgery; and advanced fellows who are studying to become intensive care physicians.
Dr. Coopersmith has established himself as one of the top investigators of sepsis and shock in the country. He served as president of the Society of Critical Care Medicine from 2015-2016, and is a member of the American Society for Clinical Investigation, which requires its members to have an outstanding record of scholarly achievement in biomedical research. His current research activity includes an NIH T32 training grant and three NIH R01 grants, two of which are collaborative studies with Emory transplant immunologist Dr. Mandy Ford that are investigating aspects of the immunological host response in sepsis.
Grant Number | Title |
---|---|
2T32GM095442-11 | Critical Care Training Program |
5R01AA027396-09 | The Impact of Chronic Alcohol Abuse on the Pathophysiology of Sepsis |
5T32GM095442-12 | Critical Care Training Program |
5T32GM095442-13 | Critical Care Training Program |
Title/Journal | Authors | Publication Date |
---|---|---|
Shock (Augusta, Ga.) |
T Yumoto, T Oami, Z Liang, EM Burd, ML Ford, JR Turner, CM Coopersmith | 12/03/2024 |
Proceedings of the National Academy of Sciences of the United States of America |
T Oami, S Abtahi, T Shimazui, CW Chen, YY Sweat, Z Liang, EM Burd, AB Farris, JT Roland, S Tsukita, ML Ford, JR Turner, CM Coopersmith | 03/05/2024 |
TiME OUT: Time-specific machine-learning evaluation to optimize ultramassive transfusion. The journal of trauma and acute care surgery |
CH Meyer, J Nguyen, A ElHabr, N Venkatayogi, T Steed, J Gichoya, JD Sciarretta, J Sikora, C Dente, J Lyons, CM Coopersmith, C Nguyen, RN Smith | 03/01/2024 |
Frontiers in immunology |
JC Anyalebechi, Y Sun, C Davis, ME Wagener, Z Liang, EM Burd, CM Coopersmith, ML Ford | 01/01/2024 |
CTLA-4 Checkpoint Inhibition Improves Sepsis Survival in Alcohol-Exposed Mice. ImmunoHorizons |
CW Paterson, KT Fay, CW Chen, NJ Klingensmith, MB Gutierrez, Z Liang, CM Coopersmith, ML Ford | 01/01/2024 |
PloS one |
EA Wilson, A Woodbury, KM Williams, CM Coopersmith | 01/01/2024 |
Shock (Augusta, Ga.) |
T Oami, T Yumoto, T Shimazui, S Sarmiento, NJ Klingensmith, CW Chen, S Otani, Z Liang, EM Burd, ZK Mahdi, ML Ford, CM Coopersmith | 08/01/2023 |
Clinical science (London, England : 1979) |
JC Williams, ML Ford, CM Coopersmith | 06/14/2023 |
Shock (Augusta, Ga.) |
DB Chihade, P Smith, DA Swift, S Otani, W Zhang, CW Chen, LA Jeffers, Z Liang, T Shimazui, EM Burd, AB Farris, BS Staitieh, DM Guidot, ML Ford, M Koval, CM Coopersmith | 04/01/2023 |
Impact of chronic alcohol exposure on conventional and regulatory murine T cell subsets. Frontiers in immunology |
CW Paterson, MB Gutierrez, CM Coopersmith, ML Ford | 01/01/2023 |
JCI insight |
NJ Klingensmith, KT Fay, DA Swift, JM Bazzano, JD Lyons, CW Chen, M Meng, KM Ramonell, Z Liang, EM Burd, CA Parkos, ML Ford, CM Coopersmith | 08/22/2022 |
The Journal of clinical investigation |
S Pal, DS Perrien, T Yumoto, R Faccio, A Stoica, J Adams, CM Coopersmith, RM Jones, MN Weitzmann, R Pacifici | 06/15/2022 |
Shock (Augusta, Ga.) |
Y Sun, T Oami, Z Liang, AA Miniet, EM Burd, ML Ford, CM Coopersmith | 10/01/2021 |
TIGIT modulates sepsis-induced immune dysregulation in mice with preexisting malignancy. JCI insight |
W Zhang, JC Anyalebechi, KM Ramonell, CW Chen, J Xie, Z Liang, DB Chihade, S Otani, CM Coopersmith, ML Ford | 06/08/2021 |
Tumor-Specific T Cells Exacerbate Mortality and Immune Dysregulation during Sepsis. Journal of immunology (Baltimore, Md. : 1950) |
CW Chen, KB Bennion, DA Swift, KN Morrow, W Zhang, T Oami, CM Coopersmith, ML Ford | 05/15/2021 |
JCI insight |
Y Sun, JC Anyalebechi, H Sun, T Yumoto, M Xue, D Liu, Z Liang, CM Coopersmith, ML Ford | 03/08/2021 |
The IL-27 receptor regulates TIGIT on memory CD4+ T cells during sepsis. iScience |
KN Morrow, Z Liang, M Xue, DB Chihade, Y Sun, CW Chen, CM Coopersmith, ML Ford | 02/19/2021 |
The Journal of clinical investigation |
M Yu, S Pal, CW Paterson, JY Li, AM Tyagi, J Adams, CM Coopersmith, MN Weitzmann, R Pacifici | 02/15/2021 |
Journal of immunology (Baltimore, Md. : 1950) |
Y Sun, J Xie, JC Anyalebechi, CW Chen, H Sun, M Xue, Z Liang, KN Morrow, CM Coopersmith, ML Ford | 12/15/2020 |
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019. Critical care medicine |
SC Auld, M Caridi-Scheible, JM Blum, C Robichaux, C Kraft, JT Jacob, CS Jabaley, D Carpenter, R Kaplow, AC Hernandez-Romieu, MW Adelman, GS Martin, CM Coopersmith, DJ Murphy | 09/01/2020 |
Breaking the bond between tetranectin and HMGB1 in sepsis. Science translational medicine |
CW Paterson, ML Ford, CM Coopersmith | 04/15/2020 |
Preexisting malignancy abrogates the beneficial effects of CXCR4 blockade during sepsis. Journal of leukocyte biology |
W Zhang, DB Chihade, J Xie, CW Chen, KM Ramonell, Z Liang, CM Coopersmith, ML Ford | 03/01/2020 |
PloS one |
BP Yoseph, E Breed, CE Overgaard, CJ Ward, Z Liang, ME Wagener, DR Lexcen, ER Lusczek, GJ Beilman, EM Burd, AB Farris, DM Guidot, M Koval, ML Ford, CM Coopersmith | 01/01/2020 |
2B4 but not PD-1 blockade improves mortality in septic animals with preexisting malignancy. JCI insight |
CW Chen, M Xue, W Zhang, J Xie, CM Coopersmith, ML Ford | 11/14/2019 |
Shock (Augusta, Ga.) |
JD Lyons, CW Chen, Z Liang, W Zhang, DB Chihade, EM Burd, AB Farris, ML Ford, CM Coopersmith | 06/01/2019 |
Increased attrition of memory T cells during sepsis requires 2B4. JCI insight |
J Xie, CW Chen, Y Sun, SJ Laurie, W Zhang, S Otani, GS Martin, CM Coopersmith, ML Ford | 05/02/2019 |
The small heat shock protein HSPB1 protects mice from sepsis. Scientific reports |
ER Breed, CA Hilliard, B Yoseph, R Mittal, Z Liang, CW Chen, EM Burd, LP Brewster, LM Hansen, RL Gleason, TK Pandita, ML Ford, CR Hunt, CM Coopersmith | 08/21/2018 |
Shock (Augusta, Ga.) |
NJ Klingensmith, CW Chen, Z Liang, EM Burd, AB Farris, JL Arbiser, ML Ford, CM Coopersmith | 08/01/2018 |
PloS one |
J Xie, JM Robertson, CW Chen, W Zhang, CM Coopersmith, ML Ford | 01/01/2018 |
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.